ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2280

Transcriptomic Analysis of Hidradenitis Suppurativa Skin Demonstrates Dysregulation of Antimicrobial Proteins and Inflammatory Pathways

Victoria Shanmugam1, Derek Jones2, Matthew Bendall3 and Keith Crandall4, 1Rheumatology, The George Washington University, Washington, DC, 2The George Washington University, Washington, DC, 3Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, 4Department of Biology, The George Washington University, Washington, DC

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: interferons, leukocytes and transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory disease of the apocrine sweat glands. The purpose of the current study was to identify transcripts and upstream regulators that are differentially expressed in HS skin specimens compared to normal skin harvested at abdominoplasty.

Methods:

Surgical specimens from operative HS debridement (n=10, IRB 041408) and abdominoplasty (n=11, IRB 101419) were collected. Total RNA was extracted, amplified, biotin-labeled, purified and hybridized to Illumina HumanHT-12 v4 Expression BeadChips and scanned using a HiScanSQ system (Illumina Inc., CA). Low-level analysis of raw BeadChip data was performed using the limma and beadarray packages.  Differentially expressed genes were detected by fitting gene-wise linear models to the normalized expression data at a false discovery rate (FDR) of <0.05 and an absolute log2-fold change greater than or equal to abs(logFC)≥1.00 (equivalent to 2.0 fold changes). Differentially expressed genes were modelled using Ingenuity Pathway Analysis (IPA, Ingenuity, Qiagen, CA) and upstream regulator analysis was performed.

Results:

In the HS to normal control comparison, 436 genes were overexpressed and 363 genes were under-expressed. The top 25 differentially expressed genes are shown in Figure 1. Notably, Dermicidin an antimicrobial protein normally found in human sweat was significantly downregulated in the HS specimens. Significant differential expression was observed in 30 canonical pathways in the HS samples based on a –log(p-value) cut off of 1.3 and a Z -score activation prediction cut off of >2 or <-2, (Table 1). Upstream regulator analysis identified  interferon alpha (IFN-α), IFN-γ, lipopolysaccharide, tumor necrosis factor and oncostatin-M as the top five upstream regulators in the HS dataset compared to normal skin (Table 2).

Conclusion:

Production of antimicrobial peptides is dysregulated in HS, and inflammatory pathways, particularly the interferon pathway and pathways of leukocyte activation are upregulated suggesting novel pathways that could be therapeutic targets for the management of this disease.

 

 

 

 

Figure 1. Differential gene expression in HS and normal tissue.

 

 

 

 

 

 

 

 

Table 1: Top 30 canonical pathways in HS

 

Ingenuity Canonical Pathways

-log(p-value)

Ratio

z-score

Down-regulated

No change

Upregulated

1

Interferon Signaling

7.87

0.528

4.24

2/36 (6%)

0/36 (0%)

17/36 (47%)

2

Leukocyte Extravasation Signaling

7.4

0.27

2.10

19/211 (9%)

0/211 (0%)

38/211 (18%)

3

Th1 Pathway

6.07

0.289

3.77

6/135 (4%)

0/135 (0%)

33/135 (24%)

4

Th2 Pathway

4.86

0.26

2.65

9/150 (6%)

0/150 (0%)

30/150 (20%)

5

Role of NFAT in Regulation of the Immune Response

4.29

0.237

3.68

11/186 (6%)

0/186 (0%)

33/186 (18%)

6

Tec Kinase Signaling

4.24

0.241

2.20

14/170 (8%)

0/170 (0%)

27/170 (16%)

7

Dendritic Cell Maturation

3.59

0.223

3.48

10/193 (5%)

0/193 (0%)

33/193 (17%)

8

Neuroinflammation Signaling Pathway

3.19

0.196

3.71

19/311 (6%)

0/311 (0%)

42/311 (14%)

9

JAK/Stat Signaling

3.13

0.265

2.13

5/83 (6%)

0/83 (0%)

17/83 (20%)

10

Oncostatin M Signaling

3.1

0.353

3.32

0/34 (0%)

0/34 (0%)

12/34 (35%)

11

FcγRIIB Signaling in B Lymphocytes

3.08

0.302

2.00

4/53 (8%)

0/53 (0%)

12/53 (23%)

12

IL-6 Signaling

3.06

0.234

2.04

8/128 (6%)

0/128 (0%)

22/128 (17%)

13

Production of Nitric Oxide and Reactive Oxygen Species in Macrophages

2.96

0.211

3.48

16/194 (8%)

0/194 (0%)

25/194 (13%)

14

TREM1 Signaling

2.54

0.253

3.44

1/75 (1%)

0/75 (0%)

18/75 (24%)

15

p70S6K Signaling

2.52

0.22

2.04

12/132 (9%)

0/132 (0%)

17/132 (13%)

16

iCOS-iCOSL Signaling in T Helper Cells

2.38

0.22

2.40

7/123 (6%)

0/123 (0%)

20/123 (16%)

17

PKCθ Signaling in T Lymphocytes

2.19

0.211

2.75

6/133 (5%)

0/133 (0%)

22/133 (17%)

18

Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses

1.76

0.197

2.84

5/137 (4%)

0/137 (0%)

22/137 (16%)

19

Acute Phase Response Signaling

1.7

0.188

3.27

5/170 (3%)

0/170 (0%)

27/170 (16%)

20

LPS/IL-1 Mediated Inhibition of RXR Function

1.69

0.18

2.14

20/222 (9%)

0/222 (0%)

20/222 (9%)

21

GP6 Signaling Pathway

1.63

0.194

2.75

6/134 (4%)

0/134 (0%)

20/134 (15%)

22

Retinoic acid Mediated Apoptosis Signaling

1.58

0.226

2.50

3/62 (5%)

0/62 (0%)

11/62 (18%)

23

Tumoricidal Function of Hepatic Natural Killer Cells

1.53

0.292

2.24

0/24 (0%)

0/24 (0%)

7/24 (29%)

24

B Cell Receptor Signaling

1.45

0.178

2.48

7/191 (4%)

0/191 (0%)

27/191 (14%)

25

PPAR Signaling

1.44

0.2

-2.52

7/95 (7%)

0/95 (0%)

12/95 (13%)

26

Thrombopoietin Signaling

1.42

0.215

2.14

3/65 (5%)

0/65 (0%)

11/65 (17%)

27

Calcium-induced T Lymphocyte Apoptosis

1.37

0.212

2.11

3/66 (5%)

0/66 (0%)

11/66 (17%)

28

SAPK/JNK Signaling

1.33

0.192

2.24

6/104 (6%)

0/104 (0%)

14/104 (13%)

29

PI3K Signaling in B Lymphocytes

1.32

0.185

2.13

8/130 (6%)

0/130 (0%)

16/130 (12%)

30

Telomerase Signaling

1.31

0.189

2.36

8/111 (7%)

0/111 (0%)

13/111 (12%)

Table 2: Top upstream regulators in HS

Upstream Regulator

Predicted Activation State

Activation z-score

p-value of overlap

Interferon alpha

Activated

8.489

1.26E-26

IFNG

Activated

9.593

1.08E-20

lipopolysaccharide

Activated

9.683

2.63E-20

TNF

Activated

7.927

1.52E-19

OSM

Activated

7.511

6.33E-18

 


Disclosure: V. Shanmugam, None; D. Jones, None; M. Bendall, None; K. Crandall, None.

To cite this abstract in AMA style:

Shanmugam V, Jones D, Bendall M, Crandall K. Transcriptomic Analysis of Hidradenitis Suppurativa Skin Demonstrates Dysregulation of Antimicrobial Proteins and Inflammatory Pathways [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/transcriptomic-analysis-of-hidradenitis-suppurativa-skin-demonstrates-dysregulation-of-antimicrobial-proteins-and-inflammatory-pathways/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptomic-analysis-of-hidradenitis-suppurativa-skin-demonstrates-dysregulation-of-antimicrobial-proteins-and-inflammatory-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology